| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,597 | 11,031 | 10,490 | 16,321 | | Cost of Revenue | 5,236 | 5,575 | 5,535 | 7,329 | | | Gross Profit | 6,361 | 5,456 | 4,955 | 8,992 | | | Operating Expenses | | Research Development | 3,094 | 2,291 | 2,682 | 2,768 | | Selling General and Administrative | 2,946 | 3,353 | 3,316 | 3,468 | | Non Recurring | 40 | 328 | 5,831 | 815 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 281 | (516) | (6,874) | 1,941 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 143 | 43 | (291) | | Earnings Before Interest And Taxes | 332 | (373) | (6,831) | 1,650 | | Interest Expense | 92 | 79 | 86 | 87 | | Income Before Tax | 240 | (452) | (6,917) | 1,563 | | Income Tax Expense | 108 | (149) | (506) | 648 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 132 | (303) | (6,411) | 915 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 132 | (303) | (6,411) | 915 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $132 | ($303) | ($6,411) | $915 |
|
0.31% Nasdaq 
0.05%
Income Statement
